Symptomtext
DTaP-IPV portion of the pentacel was reconstituted with quadracel, instead of the Hib diluent supplied with no reported adverse event; DTaP-IPV portion of the pentacel was reconstituted with quadracel, instead of the Hib diluent supplied, giving the patient an extra dose of the DTaP-IPV with no reported adverse event; Initial information received on 29-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1 years old male patient who had vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] and DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] and it was reported dtap-ipv portion of the pentacel was reconstituted with quadracel, instead of the hib diluent supplied with no reported adverse event and dtap-ipv portion of the pentacel was reconstituted with quadracel, instead of the hib diluent supplied, giving the patient an extra dose of the dtap-ipv with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Jul-2022, the patient received a dose of 0.5 ml of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot UJ673AA, expiration date: 27-Apr-2023, via intramuscular route in the left thigh as Immunisation On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE lot number not reported in unknown administration site as Immunization. Lot number was requested. On 28-JUL-2022 the dtap-ipv portion of the pentacel was reconstituted with quadracel, instead of the hib diluent supplied with no reported adverse event (product preparation error) and dtap-ipv portion of the pentacel was reconstituted with quadracel, instead of the hib diluent supplied, giving the patient an extra dose of the dtap-ipv with no reported adverse event (extra dose administered) same day following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE and (unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for all the events At time of reporting, the outcome was Unknown for all. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.